Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex. [electronic resource]
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Nov 2010
- 3787-91 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1460-2385
10.1093/ndt/gfq456 doi
Adult Angiomyolipoma--drug therapy Humans Kidney--pathology Kidney Neoplasms--drug therapy Magnetic Resonance Imaging Male Sirolimus--therapeutic use TOR Serine-Threonine Kinases--antagonists & inhibitors Tuberous Sclerosis--drug therapy